» Articles » PMID: 25448127

Bone Healing Around Nanocrystalline Hydroxyapatite, Deproteinized Bovine Bone Mineral, Biphasic Calcium Phosphate, and Autogenous Bone in Mandibular Bone Defects

Overview
Date 2014 Dec 3
PMID 25448127
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The individual healing profile of a given bone substitute with respect to osteogenic potential and substitution rate must be considered when selecting adjunctive grafting materials for bone regeneration procedures. In this study, standardized mandibular defects in minipigs were filled with nanocrystalline hydroxyapatite (HA-SiO), deproteinized bovine bone mineral (DBBM), biphasic calcium phosphate (BCP) with a 60/40% HA/β-TCP (BCP 60/40) ratio, or particulate autogenous bone (A) for histological and histomorphometric analysis. At 2 weeks, percent filler amongst the test groups (DBBM (35.65%), HA-SiO (34.47%), followed by BCP 60/40 (23.64%)) was significantly higher than the more rapidly substituted autogenous bone (17.1%). Autogenous bone yielded significantly more new bone (21.81%) over all test groups (4.91%-7.74%) and significantly more osteoid (5.53%) than BCP 60/40 (3%) and DBBM (2.25%). At 8 weeks, percent filler amongst the test groups (DBBM (31.6%), HA-SiO (31.23%), followed by BCP 60/40 (23.65%)) demonstrated a similar pattern and was again significantly higher as compared to autogenous bone (9.29%). Autogenous bone again exhibited statistically significantly greater new bone (55.13%) over HA-SiO (40.62%), BCP 60/40 (40.21%), and DBBM (36.35%). These results suggest that the osteogenic potential of HA-SiO and BCP is inferior when compared to autogenous bone. However, in instances where a low substitution rate is desired to maintain the volume stability of augmented sites, particularly in the esthetic zone, HA-SiO and DBBM may be favored.

Citing Articles

Combined use of deproteinized bovine bone mineral and α-tricalcium phosphate using gelatin carriers.

Fujioka-Kobayashi M, Urbanova V, Lang N, Katagiri H, Saulacic N BMC Oral Health. 2025; 25(1):275.

PMID: 39984888 PMC: 11846255. DOI: 10.1186/s12903-025-05644-9.


A novel technique to harvest bone autografts with mild local hyperthermia and enhanced osteogenic bone quality: a preclinical study in dogs.

Zhou T, Gan Z, Zhang H, Liu Z, Pu Y, Rong M BMC Oral Health. 2023; 23(1):838.

PMID: 37936153 PMC: 10631188. DOI: 10.1186/s12903-023-03611-w.


Revolutionizing bone regeneration: advanced biomaterials for healing compromised bone defects.

Awad K, Ahuja N, Yacoub A, Brotto L, Young S, Mikos A Front Aging. 2023; 4:1217054.

PMID: 37520216 PMC: 10376722. DOI: 10.3389/fragi.2023.1217054.


Pharmacodynamics and acute toxicity studies of Shangke Jiegu tablet with or without cinnabar.

Wang T, Han N, Li Q, Yang M, Xi H, Liu Z Heliyon. 2023; 8(12):e12144.

PMID: 36590508 PMC: 9800192. DOI: 10.1016/j.heliyon.2022.e12144.


Addition of Synthetic Biomaterials to Deproteinized Bovine Bone Mineral (DBBM) for Bone Augmentation-A Preclinical In Vivo Study.

Fujioka-Kobayashi M, Katagiri H, Lang N, Imber J, Schaller B, Saulacic N Int J Mol Sci. 2022; 23(18).

PMID: 36142427 PMC: 9505841. DOI: 10.3390/ijms231810516.